Vidarabine
Records for this ingredient, by country (identity only).
ATC J05AB · 2 markets · 95 records
CN 90 records · 2 shown of 2
- 200 mg per mL / per unit basis not statedinjectionManufacturer: 一品红生物医药有限公司 ×8Manufacturer: 三才石岐制药股份有限公司、Manufacturer: 南京海辰药业股份有限公司、Manufacturer: 双鹤药业(海南)有限责任公司、Manufacturer: 国药一心制药有限公司、Manufacturer: 大同五洲通制药有限责任公司、Manufacturer: 广东众生药业股份有限公司、Manufacturer: 广东隆赋药业股份有限公司、Manufacturer: 广州万正药业有限公司 +11
- 100 mg per mL / per unit basis not statedinjectionManufacturer: 一品红生物医药有限公司 ×8Manufacturer: 南京海辰药业股份有限公司、Manufacturer: 双鹤药业(海南)有限责任公司、Manufacturer: 吉林敖东洮南药业股份有限公司、Manufacturer: 国药一心制药有限公司、Manufacturer: 大同五洲通制药有限责任公司、Manufacturer: 广东众生药业股份有限公司、Manufacturer: 广东隆赋药业股份有限公司、Manufacturer: 广州万正药业有限公司 +10
JP 5 records · 2 shown of 2
- 3 %/1 gtopicalアラセナ-Aクリーム3%アラセナ-A軟膏3%、ビダラビン3%軟膏、ビダラビンクリーム3%「マルホ」
- 300 mg per mL / per unit basis not statedinjectionアラセナ-A点滴静注用300mg
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
Also called: 单磷酸阿糖腺苷 nickname
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.